Latest ACE inhibitors Stories
BALTIMORE, July 6, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) announced today that the U.S. Food and Drug Administration (US FDA) has granted final approval for its Amlodipine / Benazepril 5mg/40mg, and 10mg/40mg capsules. Commercial shipments of the product have already commenced.
The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients.
A drug used to treat high blood pressure may reduce the risk of kidney failure in obese patients.
Elderly patients prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) had a higher risk of kidney failure and death.
WOODCLIFF LAKE, N.J., Jan. 3, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began shipping all strengths of amlodipine besylate and benazepril hydrochloride capsules, the generic version of Novartis' LotrelÂ®.
MORRISTOWN, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc.
BURLINGTON, Mass., Sept.
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data.
Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics.
- The act of sweetening by admixture of some saccharine substance.